|
Q2 FY2027
As of Aug 30, 2026
|
Q1 FY2027
As of May 31, 2026
|
Q4 FY2026
As of Mar 1, 2026
|
Q3 FY2026
As of Nov 30, 2025
|
Q2 FY2026
As of Aug 31, 2025
|
Q1 FY2026
As of Jun 1, 2025
|
Q4 FY2025
As of Mar 2, 2025
|
Q3 FY2025
As of Dec 1, 2024
|
Q2 FY2025
As of Sep 1, 2024
|
Q1 FY2025
As of Jun 2, 2024
|
Q4 FY2024
As of Mar 3, 2024
|
Q3 FY2024
As of Nov 26, 2023
|
Q2 FY2024
As of Aug 27, 2023
|
Q1 FY2024
As of May 28, 2023
|
Q4 FY2023
As of Feb 26, 2023
|
Q3 FY2023
As of Nov 27, 2022
|
Q2 FY2023
As of Aug 28, 2022
|
Q1 FY2023
As of May 29, 2022
|
Q4 FY2022
As of Feb 27, 2022
|
Q3 FY2022
As of Nov 28, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities (Note 3) | ||||||||||||||||||||
| Accounts receivable, less allowance for credit losses of $119 and $111, respectively | ||||||||||||||||||||
| Inventories (Note 4) | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating right-of-use assets (Note 5) | ||||||||||||||||||||
| Goodwill and other intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Operating lease liabilities (Note 5) | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Dividend Payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term operating lease liabilities (Note 5) | ||||||||||||||||||||
| Non-current income taxes payable (Note 4) | ||||||||||||||||||||
| Deferred income taxes (Note 9) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, $1 par value per shares-authorized, 500,000 shares; issued, none | ||||||||||||||||||||
| Common Stock, Shares Authorized (in shares) | ||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share (in dollars per share) | ||||||||||||||||||||
| Shareholders' equity (Note 8) | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Stockholders' Equity, Including Treasury Stock | ||||||||||||||||||||
| Less treasury stock, at cost | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
